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Summary 
 International trade in medicinal herbal products is growing, while value chains are becoming 
more complex and governed by a range of public and private standards.  There is a debate 
over the extent to which phytomedicine production can be beneficial for farmers in low and 
middle income countries.  More generally, there are varied views about the extent to which 
small farmers are disadvantaged by stringent public health and private consumer standards 
in northern markets for agricultural products.  This paper proves a comparative analysis of 
value chains, using case studies of turmeric production in India.  It marries a qualitative 
investigation of turmeric producing sites in India with an investigation into the chemical 
quality of various turmeric products.  The aim of the paper is to understand the way that 
varied structure and governance of value chains changes the benefits to both producer and 
consumer.  When production is for the organic northern market, we found evidence of a 
‘captive’ value chain, where the lead firm requires strict adherence to conditions of 
production and processing.  Prices for farmers were relatively stable, at a reasonably high 
level.  In contrast, where farmers were producing for local markets, including the major 
auction at Erode, prices were volatile and farmers bore considerable risk.  We found that 
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competition and volatility in the market-based chain can lead to turmeric adulteration and 
contamination, both intentional and unintentional.   Our case study suggests that many small 
turmeric farmers would find it difficult to meet both public and private health standards, in 
contrast to some academic literature that argues that public health standards do not 
discriminate against small farmers.  More than this, our study adds to the discussion of the 
impact of standards, suggesting clear consumer benefits in northern markets.  However, 
there are also indications that only larger and more dynamic farmers can participate in the 
lucrative phytomedicine trade.  As such, our study tentatively supports previous literature 
suggesting that the application of standards in northern markets lead to increasing farmer 
differentiation.  
KEY WORDS: phytomedicines, value chains, standards, turmeric, India, herbal products 
 
Introduction  
While there is a long history of trade in phytomedicine, (defined as medicinal products 
prepared from plants and used in the form of extracts or ground plant material), growth in the 
last few decades has been particularly rapid (Robinson & Zhang 2012:5-6).  Inconsistent 
terminology confounds clarity on production estimates, but the value of traditional medicine 
production (including herbal, mineral and animal products) was estimated to be worth US$83 
Billion in 2008 (Robinson and Zhang, 2012), on par with the American weight loss industry ($ 
61 Billion) (LaRosa, 2011) or the worldwide cosmetics industry ($170 Billion) (Romanowski, 
2010).  Further, medicinal plant trade may be even more volatile than standard agricultural 
trade, as it is susceptible not only to weather shocks and disease outbreaks, but also to 
rapid changes in consumer fashions. Heinrich et al (2011) note that the declaration of an 
herbal medicinal product as a superfood leads to sudden consumer booms and rapid price 
rises.i  A prime example is Honeysuckle, which is used in Influenza treatments and has 
recently been added to health drinks in China; consequently the price has increased from a 
stable average of US$20 per kilo over the period 2004 to 2008 to almost US$100 per kilo in 
2010 (Yeoh, 2010).  This price volatility is likely to be greater at the level of the individual 
country, as global market volatility is compounded by sudden changes in the sourcing 
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practices of dominant buyers, who provide access to lucrative Northern markets (Neimark 
2012:431-2). 
This article will use the example of turmeric from India to explain how, along with changes in 
trade and production volumes, the nature of the value chains that link producer with 
consumer have grown more complex. Using an innovative multi-disciplinary approach, this 
paper is able to comments not only on market outcomes and participation, but also on 
product quality by including a study of chemical composition.  
Overall the paper argues that in the case study areas, farmers who can sell medicinal 
turmeric to quality-controlled export markets are able to achieve more stable prices than 
those that sell it for food use in local markets.  This in itself is unsurprising.  What is of 
interest is the way that both public and private standards change market outcomes and 
participation.  We shall see that there has been a debate about the impact of standards, 
commonly separated into public and private standards.  Standards, like state-encoded health 
standards, may be thought of as public, as states regulate and enforce these standards.  An 
example of the relevant public health standards in this case, are those produced and 
encoded by The Food Standards Agency (FSA) who are responsible for the safety and 
quality of foods and food supplements in the UK.  Private standards are those that are 
adopted voluntarily by companies or organizations, even though they may be codified at the 
international level.  In this case study, organic production is defined as a private standard. 
We find that standard setting forces lead firms into closer relationships with producers.  For 
consumers of turmeric, this leads to a superior product if assessed in terms of pesticide, 
colorant and preservative addition, as well as active chemical compounds. There are clearly 
benefits for farmers who can participate in these higher value chains. However, these are 
likely to be large or middle-sized dynamic farmers.  As such the paper is important in 
extending our understanding of the impact of public and private standards on the benefits of 
trade (Melo et al 2014). 
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The overall implication of our research is that the constrained access to high value Northern 
markets and the complex public and private regulation of medicinal turmeric means that only 
richer farmers can participate.  However, the quality of the product is far higher than that in 
unregulated markets, where market competition and volatility lead to adulteration.  This 
paper contributes to the small literature on global value chains (GVCs) in phytomedicine.  In 
its discussion of a ‘captive’ value chain, using the definitions set out in Gereffi et al (2005), 
our research also confirms many of the concerns raised in wider literature on food safety 
regulations and quality standards. Importantly, it adds to the debate over the impact of 
standards by combining qualitative analysis with the chemical analysis of turmeric products.  
Linking the results allows us to consider some aspects of the impact of standards commonly 
excluded in the literature – that is the impact for consumers. 
In methodological terms, the choice of contrastive case studies, semi-structured interviewing 
and non-participant observation has its strengths in uncovering the dynamics behind 
participation in particular value chains.  However, it does preclude making strong statements 
about the net impact of various kinds of value chain on producers.  At the same time, given 
the complexity of the issues raised by the trade in phytomedicines, this paper illustrates how 
inter-disciplinary approaches can give new insights. 
The paper first reviews the literature on the impact of standards in agricultural value chains, 
before setting out the nature of phytomedicine production in India.  The case study and 
research methods will then be outlined.  The first of two results sections will describe the 
various value chains for turmeric, while the second will set out the character of standards 
and governance in those chains.  The article ends with a discussion of the implications of 
this research for the wider debate over the value of agricultural standards and the impact of 
phytomedicine trade. 
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Trade and standards in agri-food value chain framework 
Barrett et al (2012) argue that the emergence of export value chains benefits participant 
farmers, who will improve their productivity and profitability, and in doing so, contribute to 
economic development.  However, they recognize that the size of the benefit to participating 
farmers is uncertain, and is likely to be smaller where there are unanticipated risks or where 
buyers enjoy contractual bargaining power over farmers.  There has been a long debate 
over the impact of contract farming (see Bellemare 2012, Masakure & Henson 2005).  
Bellemare’s (2012) study of the impact of contract farming in Madagascar suggested a small 
positive income benefit, using an innovative statistical methodology that attempted to control 
for the differences between contract farming participants and non-participants.  However, 
much of the debate has moved away from looking at average impacts to looking at the 
distributional impacts, with Watts arguing that contract farming promotes social 
differentiation (1994:54). 
The GVC approach, with its investigation of power relations in agri-food chains (Fullbright, 
2008; Gibbon and Ponte, 2005; Kaplinsky, 2004), can illuminate some of the reasons for 
differential outcomes, but has only been applied in a limited way to medicinal plant products.  
Where research has taken place, there is a concern that significant power imbalances in the 
chain work against producers and Neimark (2012:424) has referred to these imbalances as 
‘green grabbing’, arguing that the collectors of plants are at extreme disadvantage to 
pharmaceutical companies.   
The strengths and weaknesses of the GVC approach have been debated widely, with 
concern that it cannot effectively analyze consumption and employment (Smith et al., 2002; 
Bernstein and Campling, 2006; Bair, 2005; Palpacuer, 2008; Riisgaard 2009).  The GVC 
analysis usually ends at the level of the retailer (rather than consumer) and begins with the 
farmer (rather than the farmworker) (Bair, 2005).  Similarly, our paper does not investigate 
how the demand for turmeric is formed in Northern markets, neither does it consider the 
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environmental, gender or labor issues related to turmeric production.  As such, the study 
raises issues for future investigation.ii   
Using the GVC approach, many authors suggest that lead firms have increasing power in 
agricultural value chains due both to greater market concentration and more stringent food 
safety regulations in northern retail markets (e.g. Selwyn, 2007; Ortiz and Aparicio 2007).  
Thus, the application of public and private regulations is a key issue in shaping power 
relations in agricultural value chains.  Among the positive effects of regulations, they 
generate a common language for all in the value chain and stimulate demand by increasing 
consumer confidence (Melo et al 2014).  On the negative side, certain farmers suffer due to 
an inability to meet standards.  Crucially Melo et al (2014) argue that the impacts are 
complex and extrapolating from one example of standards imposition can result in 
misleading estimates of their impact.  However, Coslovsky (2014:33) summarizes the 
empirical evidence to suggest that small producers, those in the poorest countries, and 
those exporting lightly processed commodities tend to experience the largest losses when 
standards are introduced.  
In their review of the literature, Hansen and Trifkovic (2014) argue that the impact of food 
standards may induce negative externality effects on poor farmers because the inability to 
comply with food safety and quality standards in high value markets can result in selling to 
far less profitable alternatives. Similarly, they argue that it could be the case that the richest 
farmers already received high prices (for their high quality output) and so find that there is no 
gain from adopting new standards.  In their study of the impact of standards on the 
pangasius value chain in Vietnam, the overall outcome of food standards seems to be 
positive only for upper-middle class farmers, while others only benefit from better labor 
market opportunities.  However, not all standards are likely to have the same impact (Melo et 
al 2014).  Tran et al’s (2013) study of the shrimp sector suggests that food safety standards 
are within reach for small-scale shrimp producers, as generally they do not use antibiotics or 
other prohibited chemicals.  However, the traceability requirements of social and 
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environmental standards lead some processors to consider producing shrimp themselves or 
to promote vertical integration with larger shrimp producers. Both approaches facilitate 
traceability, but marginalize small-scale shrimp farmers and traders, forcing them to produce 
only for less profitable and more volatile domestic and regional markets.  Thus, Tran et al 
(2013) conclude that it is private, rather than public, standards that disadvantage small 
farmers. 
 
Phytomedicine production in India 
Of the 17,000 plants to be found in India, 7,500 are known for medicinal uses (Kala et al., 
2006), with Ayurvedic medicineiii claiming to use 2,000 of these. More than 60 species are in 
great demand (Patwardhan et al., 2005), with the annual turnover of the Indian herbal 
medicine industry estimated between US$377 million and US$1 billion per annum  (Kala et 
al., 2006; Sharma et al., 2008). A recent study commissioned by India’s National Medicinal 
Plants Board (NMPB) has estimated that 177,000 metric tons of medicinal plants are used 
each year by India’s domestic herbal industry, that 86,000 metric tons are employed within 
rural Indian households, and that 56,500 metric tons are exported through international trade 
(Cavaliere, 2010).  While Indian exports, valued at US$132 million in 2008, contributed less 
than 0.2% to the global herbal market, growth is rapid and Indian companies are fast 
emerging as key international suppliers of medicinal plants.  
The structure of the industry is diverse.  Herbal medicinal products are produced by several 
thousand companies in India, most of whom are quite small, including numerous 
neighborhood pharmacies that compound ingredients to make their own remedies 
(Dharmananda, 2003).  The exact number of manufacturers is unclear, with estimates 
ranging between 1,200 and 6,000 licensed manufacturers  (Subrat et al., 
2002),(Polshettiwar, 2006).  However, it is generally agreed that the formal sector of the 
industry is dominated by around a dozen major companies, most of whom produce products 
other than phytomedicines, such as foods and toiletries (Dharmananda, 2003). In 2012, 
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Emami was the leading company, with a market value share of 17%, followed by Darbur 
(16%) and Proctor and Gamble (11%), reflecting a more general rise in market presence 
from non-Indian companies (Euromonitor, 2013). These manufacturers are supplied by local 
or national markets, directly from farms or commonly through middlemen representing wild 
pickers. The vast majority of medicinal plant species used in India to make herbal medicinal 
products (HMPs) are still collected from the wild although there is evidence to suggest that 
some companies are developing more sustainable cultivation strategies (Cavaliere, 2010), 
The globalization of Ayurvedic practices has gained momentum over the last twenty years 
and Ayurvedic products are used as food supplements in the USA, Europe and Japan. 
(Ravishankar and Shukla, 2007).  Certainly, exports of herbal products from India increased 
to US$128 Million in 2009-10, from US$69 Million in 2005-06, recording a compounded 
annual growth rate of 16.8 per cent. Between 2007 and 2010, the top five export 
destinations were USA, Pakistan, Germany, Japan, and the UK (Scindia, 2010).  However, 
the UK share declined in relative and absolute terms over this period (from $3.7 million in 
2007-08 to $3.2 Million in 2009-10).  This may be as a result of the implementation of the 
THMPD which, it has been argued, raises the entry bar for producers of these types of plant 
based medicines to enter the European market (Patwardhan, 2011). Professional 
practitioners of Traditional Indian Medicine (TIM), including Ayurveda, are scarce in the UK 
compared with Western herbalists or Traditional Chinese Medicine (TCM) practitioners and 
medicinal herbal products are generally sought out by the general public in retail health food 
shops or using online websites (Booker, 2014). 
Indeed, it has been argued that despite healthy growth in Indian medicinal plant exports, 
adulteration and contamination are commonplace and so the supply of good quality raw 
materials is limited (Patwardhan et al., 2005). With an estimated 95% of herbal species wild-
collected, the resulting depletion of wild medicinal plants affects not only bio-diversity and 
the ecology but can also have a serious detrimental impact on the livelihoods of local people 
(Kala et al., 2006).  Many argue that the cultivation of wild herbal plants should be the aim of 
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policy, along with tighter regulations on herbal-collection (Alam and Belt, 2009; Kala et al., 
2006; Schippmann et al., 2002).  
There is some agreement that the sustainable cultivation of medicinal plants would require a 
combination of support to production (to raise yields) and to processing (to improve quality) 
as well as intervention in the value chain.  The unregulated marketing system for 
phytomedicinal products means that farmers are often unaware of final market prices and 
lack knowledge of the marketing system.  Without intervention in both production and value 
chains, small farmers will continue to benefit little and that many medicinal plants are 
destined to be traded through illegal channels Kala et al., (2006), van de Kop et al., (2006) 
come to similar conclusions, pointing out that high risks, transaction costs and a lack of trust 
amongst chain actors prevent small-holder producers from taking up the cultivation of 
medicinal plants.  Assessing a project to cultivate a medicinal plant, Kutki (Picrorhiza kurroa 
Royle ex Benth.) in northern India, Alam and Belt (2009) find that the project had 
disappointing results due to poor quality of planting material, lack of irrigation, and the 
emergence of apples as a profitable cash crop, resulting in farmers switching away from 
kutki.   Alam & Belt (2009) conclude that the cultivation of medicinal plants is more difficult 
than usually portrayed in the scientific literature and government promotional material.    
 
Public-private collaborations are suggested as a way of minimizing constraints to cultivation, 
with support from agricultural extension and research agencies (Kala et al., 2006; Vaidya 
and Devasagayam, 2007; van de Kop et al., 2006).  In contrast, Shahidullah & Haque (2010) 
argue that there needs to be stronger vertical integration in the value chain, in order to 
remove barriers to market access on the part of producers, improve producers’ power in the 
chain and give manufacturers greater control over quality and supply.  
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Case study and research methods   
 
The case study phytomedicine studied here was Curcuma longa L., or turmeric.  Turmeric is 
an important phytomedicine crop, used in Ayurvedic and alternative medicine generally, as 
well as being used for food. In 2007, Indian turmeric had a total export value of US$ 14 
million. This rose to an estimated all time high of nearly US$120 million in 2012 (Spices 
Board, 2015).  In the most common form of production in India, turmeric roots are dried in 
the sun, boiled to soften, re-dried and then subjected to a polishing process to improve the 
texture and color of the root thereby making it potentially more attractive to the buyer.iv   
 
As well as food use, turmeric has various spiritual and medicinal uses in India. It is 
associated with the cleansing of the body and is commonly used by women on the last day 
of menstruation or upon marriage (Velayudhan et al., 2012).  It is indicated as an anti-
inflammatory and for the treatment of flatulence, jaundice, menstrual difficulties, hematuria, 
hemorrhage, and colic, and as an external treatment, it is used in poultices to relieve pain 
and inflammation (Thorne, 2002).  In western medicine, current research has focused on 
turmeric’s antioxidant, hepato-protective, anti-inflammatory, anti-carcinogenic, and 
antimicrobial properties, in addition to its use in cardiovascular disease and gastrointestinal 
disorders (Thorne, 2002).  Various tests have been carried out, often citing turmeric’s 
curcumin content (or a mixture of curcuminoids) as the main active ingredient (Booker et al., 
2014). The clinical effectiveness of curcumin is hampered by its poor bio-availability and 
large prescribed doses, e.g. 8 g / daily may be required to achieve any therapeutic benefit 
(Jurenka, 2009). This has led to the development of high potency curcumin extracts and 
various chemically modified spin off products purported to be more easily absorbed (Booker, 
2014). 
 
Turmeric’s use as both food and a medicine presents an opportunity to show how complex 
value chains may be for certain herbal products.  One major difference between the various 
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uses (food, ritual and medicine) is the nature of standards, and this helps us understand 
better the influence of public and private standards. The literature on standard setting and 
contract farming highlights the difficulty of investigating impact, not least because of the 
difficulty of comparing participants with non-participants who may not be similar (Barrett et al 
2012, Bellemare 2012).  Bellemare (2012) notes that, despite the potential for some 
sophisticated matching techniques, it was still difficult to completely control for the 
differences between participants and non-participants, and also that it was unclear if results 
were externally replicable, as contract farming tended to take place in very particular areas 
(such as close to roads and airports).   
 
It was important to identify sites that had experience in cultivation and trade. Karnataka and 
Tamil Nadu are major turmeric growing areas. This research uses a comparative analysis of 
commodity chains, using three case study sites that reflect two different types of turmeric 
value chain.  There are two types of value chain relationship illustrated here – using the 
definitions set out in Gereffi (2005), the research provides examples of both market-based 
and captive value chains.  The former are value chains were linkages are market-based and 
switching cost are low, while the latter are chains were small suppliers are dependent on 
much larger buyers and so are described as ‘captive’ as they face significant switching 
costs.  At the same time, in ‘captive’ value chains, there is a high degree of monitoring by 
lead firms to ensure product quality and also attempts to control the sales behavior of small 
suppliers so that they do not sell to others.  Other authors have used the term ‘vertically 
integrated’ to reflect the relative difference in power in this value chain between suppliers 
and the lead firm (e.g. Shahidullah & Haque 2010).   
 
The first case study examined a farm site located near to Shimoga in the state of Karnataka. 
This was an example of a farm that was in a captive chain, supplying at a national level a 
12 
 
primary manufacturing site in Bangalore and internationally to a secondary manufacturing 
site in the UK.   
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Market-based chain (Case Study 2, Erode)                        Captive Chain (Case Study 1, Shimoga) 
  
 
 
 
 
 
 
 
 
 
 
Figure 1: A diagrammatic comparison of the Erode and Shimoga value chains
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There are two examples of market-based chains in this research, reflecting the different end 
usages of turmeric.  The second case study is of a market-based value chain, and this 
examined a farm site near to Erode in the state of Tamil Nadu. In India, Tamil Nadu is a 
major area for the cultivation of Curcuma longa and the town of Erode, also known as 
‘turmeric city’, is regarded as the world’s largest producer and the most important trading 
center in India (Prasad and Aggarwal, 2011).  This site grew plant material that would be 
sold through middlemen at an auction house and represented the traditional route of supply 
where the plant material could be bought by any buyer for a multitude of purposes (e.g. food 
and medicinal use), including being purchased by a local manufacturing unit and once 
traded the traceability of the material was generally lost. The third site was in Jhansi, 
northern India that sold turmeric only to local market traders and had no connection with, 
and little understanding of, the industrial chain.  While there would be less confounding 
information if all three of the sites were in the same state, these sites provided a good 
comparison between a captive and market chain. 
 
Qualitative data was collected for each of the diverse value chains, using semi-structured 
interviews and non-participant observation at several points in the chain.  Semi-structured 
interviews are useful in obtaining a range of insights on a specific issue. This methodology 
had advantages over a fully structured approach in that it was less intrusive, encouraging 
two way communication. It was able to both confirm what was already known and provided 
an avenue for learning with the interview subjects being able to provide the reasons behind 
their answers as described by (FAO, 1990). Observational methods (Handley, 2012) offered 
an insight into what people do rather than what they say they do.  Moreover, an 
observational and interview approach is in line with what would be regarded as ‘best 
practice’ in research connected with GVC analysis (Kaplinsky and Morris, 2001). This 
recommends that actors at various stages of the value chain are interviewed in order to 
establish value chain dynamics.  
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Chemical analysis of 54 turmeric samples (12 extracts, 32 ground powders, 7 dried 
roots/rhizomes, 3 fresh rhizomes) was carried out using a combination of H- nuclear 
magnetic resonance (NMR) spectroscopy coupled with multivariate analysis and high 
performance thin layer chromatography (HPTLC) (Booker et al., 2014).  Both techniques 
provide different and complementary data and together they can be used to effectively 
differentiate between a wide variety of crude drug powders and herbal medicinal products, 
offering new ways to understand how chemical quality may potentially be linked to the 
governance and arrangement of a value chain.  Samples were collected from various 
sources: fresh turmeric from the local markets at case study sites 2 and 3; the product of the 
captive value chain, case study 1; and other medicinal turmeric products on sale in the UK, 
which were in powders, extracts or in tinctures.  Each sample was tested for curcuminoid 
content and its general chemical profile, and compared to the pure samples of the fresh 
product (as recorded in pharmacognosy literature). A full description of the analytical 
methods and results is provided by Booker et al. (2014). 
 
For the qualitative study, the core sample (see Table 1) was comprised of farmers, 
processors and market traders (interviewees were located when primary respondents 
recommended subsequent interviewees, i.e. through ‘snowballing’).   It proved problematic 
to interview farmworkers due to the lack of ability to communicate in regional languages.  
Some impression was gained of pay and working conditions through observation and other 
interviews, although this is likely to have been highly imperfect.  In addition to the specific 
interviewees listed in Table 1, visits were made to markets, trade fairs and Ayurvedic 
hospitals, and interviews carried out with manufacturers, regulators, local academics, NGO’s 
active in the area, exporters, and retailers.  Notes were made from the local newspapers of 
any news stories relating to export trade, agriculture and herbal medicines. 
 
Research was carried out during times of high activity in 2012.  The busy period for turmeric 
production runs from November through to April, when most harvesting, drying, processing 
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and trading takes place. Research was carried out for four months, split over two visits, one 
in January and February 2012 (Shimoga and Erode) and the second in October and 
November 2012 (revisiting the primary sites, and then travelling to Jhansi).  The primary 
author spent time interacting with the participants in order to gain their trust and attempt to 
break down some of the barriers.  Despite giving clear information about the nature of the 
project, the primary author did suspect that respondents in some cases believed that the 
research was linked to particular herbal manufacturers or to a local university that had 
provided introductions.  As such, it is unlikely that he heard the most negative aspects of 
employment on the farm or in a factory or heard grievances regarding poor pay and / or 
working conditions.  Permissions were given for interviews, and ethical approval for the 
fieldwork given by the London School of Pharmacy on 25/11/2011 (Research Ethics 
Committee References REC/B/11/01). 
 
Table 1: List of Interviewees in each value chain 
Interviewee Location Case study / chain 
Operations manager Lead firm, UK Shimoga (Case 1) 
Herbal products Director Lead firm, UK Shimoga (Case 1) 
Biolab Manager Primary processor (PP), India Shimoga (Case 1) 
Managing Director Primary processor (PP), India Shimoga (Case 1) 
Accounts Manager Primary processor (PP), India Shimoga (Case 1) 
Retail Manager Primary processor (PP), India Shimoga (Case 1) 
Production manager Primary processor (PP), India Shimoga (Case 1) 
Farm Manager Karnataka, India Shimoga (Case 1) 
Company Director Processing company, Erode Erode (Case 2) 
Director of Medicinal plant 
farm 
Medicinal plant farm Erode(Case 2) 
Forestry representative Indian Forest Service (IFS) Erode (Case 2) 
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Farm owner 1 Tamil Nadu Farm, Tamil Nadu, 
India 
Erode (Case 2) 
Farm owner 2 Tamil Nadu Farm, Tamil Nadu, 
India 
Erode (Case 2) 
Farm owner 1 Jhansi, India Jhansi (Case 3) 
Farm owner 2 Jhansi, India Jhansi (Case 3) 
 
 
 
The choice of contrastive case studies, semi-structured interviewing and non-participant 
observation is helpful in investigating the structure of particular value chains.  However, it 
does preclude making strong statements about the net impact of various kinds of value chain 
on producers, as no clearly matched control group is established, while data on costs and 
revenue is obtained from a small sample.  At the same time, given the complexity of the 
issues raised by the trade in phytomedicines, this paper does illustrate the operation of key 
features of various value chains, while the inter-disciplinary approach allows us to 
investigate quality for consumers by the use of chemical tests.  
Structure of various value chains for turmeric in India  
The structure of two value chains are sketched out here: one is the example of organic 
turmeric production for medicinal use (figure 1); the second is the domestic value chain for 
turmeric, where the product might be eventually used for local food, ritual or medicinal 
purposes.  Case study 1 fits into the first value chain, which we have categorized as a 
‘captive’ chain, while case studies 2 and 3 fit into the second type, which we have 
categorized as a market-based chain. 
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Case study 1 is set near to the city of Shimoga in the state of Karnataka.  Here we find a 
supplier of organic, medicinal quality turmeric in the form of a 30 acre farm set in 450 acres 
of forest, managed by an environmental management trust. The farm is much larger than 
most farms in the area, and indeed in India in general, where the average size farm is 
approximately 3 acres and large farms (greater than 25 acres) account for only 1.0 percent 
of the total (USDA, 2009). The farm has been certified organic since 2004, and produces 
raw herbal ingredients (including turmeric) under contract to a Bangalore manufacturing 
company who then sells on to a European manufacturer.  For turmeric, the farm received 
US$1 per kilo – more than double the amount received in Erode in 2012, although far less 
than when turmeric prices were at a high in 2010. Areca is the principal crop grown on the 
farm and provides the forest canopy under which many of the medicinal plants are 
cultivated. Many of the medicinal plants are planted randomly under the areca canopy (wild-
crafted) and there are no chemical pesticides or herbicides used and the crops in the fields 
are mostly weeded by hand.  In addition, a range of other food crops are grown. 
 
In Shimoga, the turmeric seed tubers are wild-crafted and after nine months the new root 
crop is ready for harvesting. Unlike the turmeric grown in Erode (case study 2 below), there 
is no polishing step (see fig. 1) and after drying, the rhizomes are sent to a company in 
Bangalore for processing.  The company specializes in the supply of organic medicinal 
plants for the export market and have established contracts with farmers in Karnataka and 
throughout India to buy their organically-produced crops. In turn this company has a contract 
with a retailer in the UK who will buy the plants once they have been initially processed. This 
normally involves further cleaning, drying, cutting and powdering. The secondary processing 
-the transformation into a finished product ready for sale in store - takes place in the UK.  
The Bangalore based company began trading in 1999 and currently employs 150 people.  
According to the owner, the company did not start to make a profit until year eight and in the 
early years was heavily subsidized with funds from other businesses. It continues to grow by 
20-30% each year. The company’s product range includes: medicinal plant products, 
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produced exclusively for the UK market; organic spices; organic compost; and a range of 
bio-pesticides.  Along with the medicinal plant products, almost all of the spices are exported 
but recently the company has been experimenting with a spice range for the growing 
domestic market.  
 
The Bangalore based company make direct contracts with the farmer and do not buy any 
material from market sources where traceability cannot be assured.  All of the farms who 
supply the Bangalore operation are required to be certified by an international organic 
certification body.  Both the farmer interviewed and the company respondents reported that 
farmers who contract with the company receives a 10 – 40% premium above the market 
price depending on the complexity of cultivation and the good agricultural practices that need 
to be used e.g. ginger 30-40%, turmeric 10%, coffee 10%, pepper 20%, white pepper 30%. 
The premium is adjusted depending on the conventional market price.  If the market price is 
low, the premium paid is higher, but if the market price is high, a lower premium is paid. This 
helps to achieve price stability. 
This can be contrasted with the example of production for the domestic market, in the next 
two case studies. In case study 2, at the Erode site, one farm is owned by three reasonably 
wealthy brothers, each with ten acres of land. The farm produces turmeric and sells it at the 
major auction in Erode.  In interviews, the brothers reported that they would like the 
opportunity to contract with European buyers but are less inclined to introduce organic 
farming which they consider as a more difficult process with greater risks of failure.  
However, the price of turmeric in the Erode market is prone to fluctuation.  According to 
interviews with farmers, in the 2009 / 2010 season, the price of turmeric soared to 
approximately US$247 per quintal (100kg), but by April 2012, the market price for Erode 
turmeric plummeted to below US$60 per quintal (NCDEX 2015). The farmers interviewed in 
Erode blamed this price crash on over-production resulting from the high prices seen the 
previous years.  
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Figure 2. Chart showing the auction price highs and lows for turmeric from 2008 to 2013. 
Source: NCDEX (2015) 
 
This yo-yo effect results in a situation where farmers are forced to store the dried roots until 
the price rises to an acceptable level.  However, storage facilities are still relatively basic 
and, while turmeric can be stored for up to five years, there is an appreciable risk of 
contamination from undesirable vectors such as insects and molds. At the polish stage, 
farmers may also add colorants to the turmeric to make it appear more attractive to buyers in 
order to assure a sale. 
While we can see a picture of price volatility in the local turmeric market, fortunately for most 
farmers, turmeric is grown alongside other crops. Sugar cane is often the primary crop 
grown in the Erode area due to the presence of several large sugar manufacturers who are 
able to provide some market stability. Other crops grown in the area are tapioca, coconut, 
rice, bananas, papaya, maize and okra. The dominant crops tend to reflect market prices so 
if the price is good one year, more of that crop is planted for the next year.  However, 
farmers told us that this pattern of response often has the effect of over-supplying the market 
in subsequent years, resulting in a decrease in value.  
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The third site was farm in Jhansi, northern India that sold turmeric only to local market 
traders and had no connection with, and little understanding of, the industrial chain. At this 
site in-depth interviews were conducted at a farm, less than 0.5 hectare in size, that 
produced peanuts (Arachis hypogaea) and turmeric. The farmer and his family cultivated 
turmeric to sell in the local market. It is not boiled, polished or even dried but sold directly to 
market traders after harvesting. The farmers sell the crop to middlemen for 25 rupees per kg, 
which is less than either of the other case studies. Turmeric is always grown as a ‘standby’ 
crop, in case of a sudden rise in its market value, as was seen in previous years. Using this 
strategy, the farmers have some turmeric ready to sell and have enough seed stock in the 
form of the root tubers for replanting when necessary. 
 
Standards and Governance of GVC for turmeric in India 
The two broad types of chain result are associated with different end product qualities.  I n 
the captive chain (Figure 1) there is no requirement for a polishing step and the rhizomes are 
collected for extraction immediately after drying. Moreover, the agreed contract price 
negates any need for storage and so heat sensitive compounds are more likely to remain 
intact and treatment with aggressive pesticides and preservatives is unnecessary.  
Moreover, the adherence to private standards of organic production requires that in the 
captive chain, methods of production do not involve the application of non-organic inputs, 
such as synthetic pesticides and fertilizers.  By establishing a well-managed and well 
monitored captive value chain, end companies can exert a greater degree of control over 
processes and procedures that can lead to a better quality product. The chemical analysis 
provided crucial evidence to support this by demonstrating that the samples obtained from 
the captive value chain were free from adulterants and were comparably closer in chemical 
composition to the freshest rhizomes tested than most other samples in the study (Booker et 
al., 2014). 
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This study has shown that, in the market-based value chain, methods of cultivating, storing 
and selling Curcuma longa can lead to adulteration of the supply chain.  As well as the 
mixing of incorrect curcuma species, this adulteration often takes place at the polishing 
stage, where ground powders are added to improve the color of the rhizomes. As the captive 
value chain product is not polished and is not destined to be sold at auction, (in the auction 
good color is likely to have an incremental effect on the price), product adulteration is more 
effectively controlled and prevented.  Adulteration can also happen in the market-based 
value chain during storage, when synthetic preservatives are deliberately applied or when 
poor storage facilities lead to accidental contamination.  More than that, the analysis of some 
of the samples of medicinal turmeric purchased in the UK suggested the starting material 
had been stored for long periods, resulting in deficiency of what may be important 
therapeutic compounds. 
 
Having considered the different factors determining product quality, let us turn to the 
governance of each chain.  In Shimoga (Case study 1), the risks for the farmers have been 
minimized through the establishment of contracts that guarantee an order size and a price 
for the crop. The farmers in the captive chain are directed through the buyer as to which 
plant to grow, how to cultivate and what quantity.  Farmers receive training in organic 
production and in good agricultural practices (GAP). We have already noted that farmers 
received more than twice the price for their turmeric than those in Erode at the time of 
fieldwork (although the auction price can also peak at a higher level). Interestingly, another 
benefit of the stability of the market for turmeric was that, our interviews with both farmers 
and workers suggested that while the farmworkers in the case study 1 earned the same daily 
wage as in case study 2, they had longer employment periods and far more secure forms of 
employment contract.  As such interviews suggested that they were paid about US$0.12 for 
work that produced about a kilo of turmeric in both sites.  However, in the Shimoga farm 
supplying the captive value chain, most workers seemed to have formal contracts and the 
availability of work appeared to be more consistent through the year.  In Jhansi (site three), 
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the farmers engaged on very small farms appeared to be the less affluent of all the farmers 
studied.  These farmers had no means to engage with any outside markets and relied on 
selling their unprocessed turmeric for the minimal price at local markets. Farm workers on 
these very small plots worked for food (i.e. where they are paid in kind wages) and were 
accommodated in the homestead.  As such it was hard to calculate an equivalent daily 
wage, but they seemed to have the poorest working conditions in the sample.   
 
In the Erode site (Case study 2), interviews suggested that farmers were aware of turmeric’s 
use in medicinal products and chose to sell their crop at the state-run auction house. This 
gave them the possibility of selling when the price was high and also they could take 
advantage of the storage facilities provided in the town of Erode when the market price was 
low. They expressed interest in selling directly to herbal medicine manufacturers and 
especially those outside of India but did not have the necessary linkages in place. They 
accepted that there was a market for organically produced, export-quality turmeric but lacked 
expertise in this area and were not prepared to undertake any changes that, in their view, 
could easily result in a loss of income. Paradoxically, they were unhappy with the low market 
value of the domestic market and their necessary but uncomfortable reliance on middlemen.   
 
In case study 1, the captive value chain, the quality and traceability of the raw materials used 
to manufacture phytomedicines are crucial to the domestic primary processor as they must 
adhere both to public health standards and the private, organic standard.  For the domestic 
market in India, private standards are less common and companies producing medicinal 
turmeric products often obtain their supplies through middlemen or through the state-run 
auction houses. Some Indian herbal manufacturing companies have started to produce 
organic products.  In this study, the primary processing company (PP) in Bangalore is 
contracted to supply the European manufacturer (the lead firm).  In order to achieve this, PP 
make contracts with farmers in order to fulfil the order requirements of the lead firm, and in 
this case, PP has become the major supplier of the lead firm.  At the same time, PP is reliant 
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on sales to the lead firm, with the majority of medicinal plants processed destined for 
secondary manufacture by the lead firm.  PP plans contracts with farmers in advance, based 
on market predictions from the lead firm. 
 
However, the lead firm does not only deal in India but have contracts with over one hundred 
farmers in many parts of the world, including Sri Lanka, China, Vietnam and Eastern Europe. 
Through making these contracts and paying a premium for organically produced crops, the 
lead firm is able to assert the organic nature of their products, as well as claim full 
traceability.  Moreover, in interviews it was clear that the stability of the relationships that 
they enter into allows them to present their relationships under a ‘fair trade’ ethic, which is 
useful as a marketing tool.  This represents a considerable investment for the lead firm in 
terms of time and money, as in practice this means that the lead firm must send employees 
to visit the farms on a regular basis to ensure that standards are met. Training is provided to 
the farmers, farm workers and the workers at the primary processing facilities to ensure 
compliance with the manufacturer’s product specification 
 
Discussion and implications 
The case study above serves to illuminate some of the debates about the impact of 
standards in agricultural trade.  We have seen that the most recent literature has tended to 
distinguish the impact of public and private standards on varying groups of farmers.  What 
does this qualitative, contrastive study of turmeric tell us about the impact of 
standards and international trade?  Turmeric must be understood as product sold on 
complex and interacting value chains.  This of course is true of most agricultural 
products (Tran et al 2013), and each value chain has different governance 
standards.  Both public and private standards restrict entry to the most profitable 
market for farmers – the organic medicinal chain.  Interestingly, primary processors 
are likely to find that the profitability of the domestic organic medicinal turmeric 
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market is greater than the export market (due to differences in testing costs but 
similar prices received).  In the domestic Indian medicinal market, the public 
standards are not as stringent, and indeed many local health practices advocate the 
ingestion of heavy metals (Kumar et al., 2006).  
 
Volatility and competition in the domestic market leads farmers to adopt a range of practices 
that can lead to contamination of the crop.  Farmers may add colorant in order to make their 
crop visually attractive to traders or add in other species to bulk out the crop.  Or, like the 
rosy periwinkle farmers in Neimark (2012:442)’s study, some wealthier farmers might put 
their plants in storage, in order to ride out dips in the market price.  This leads to risks of 
further contamination from pesticide and mold.  This research suggests that Tran et al’s 
(2013) conclusions about the ability of small famers to meet public food safety standards in 
shrimp may not apply in other crops.  While some of the crop contamination might disappear 
with a less volatile domestic turmeric market, other kinds of contamination are the result of 
competition in unintegrated markets and would be likely to continue. 
 
The study of turmeric also suggests a far more complex class division of farmers than is 
often recognized in value chain studies.  The simple division of farmers into ‘small vs. large’ 
is an abstraction that ignores a range of differences in the degree of capitalization, 
specialization and dependence on the market (Oya 2004).  These differences affect the way 
that farmers are able to access value chains.  While this study lacks a wider picture of 
capitalization and size distribution of farmers, it appeared from the stakeholder interviews 
that it was the largest and wealthiest farmers who were able to benefit from integration in the 
most profitable value chain with the most stringent standards.  This confirms the conclusions 
of the existing literature.  However, the qualitative information collected in this study 
suggests that integration in the organic export market was not just about size of holding, but, 
given the existence of larger farmers who were trying to switch out of agriculture, reflected 
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the degree of dependence on the agricultural market, ability to invest and, fundamentally, 
links to an appropriate processor.  This raises the need for more studies that go beyond the 
small-large dichotomy to understand agricultural success. 
 
In conclusion, the captive (or vertically integrated) chain can encourage high quality and 
increases in the productivity of cultivated turmeric.  In this sense, it provides support for 
those writers who consider vertical integration of herbal value chains a solution to the 
increasing pressure on environmental resources and the low profitability and quality of many 
Indian herbal products.  As Coslovsky (2014:33) argues, this is a case where integration with 
the lead firm improves performance on various fronts.  We saw that the lead firm worked 
with the primary processor and with farmers to improve production techniques generally, as 
well as in the specific area of organic production. This contrasts with other case studies of 
medicinal value chain production.  Neimark’s (2012:426) discussion of rosy periwinkle 
production in Madagascar suggests that pharmaceutical firms shift tasks of harvesting, 
transporting and quality control to small scale collectors in order to overcome the risks of 
contending with natural cycles and marshalling of labor.  In our study of medicinal turmeric 
production in India, it may be that the particular combination of public and private standards 
forces a very different kind of response by pharmaceutical manufacturers, who are then 
unable to delegate quality control.  
For the farmer, the benefits to producing in this chain are clear.  Prices are stable, and are 
relatively high.  Moreover, farmers receive training on improved production techniques and 
benefit from access to inputs.  However, although a captive value chain may appear to be 
more stable and less of a risk to the farmer there are some instances where the farmer may 
not benefit. Once contracted into a chain, our interviewees told us that a certain amount of 
freedom is given up and the farmer is no longer free to sell on the open market.  Finally, it 
appears that only the largest and most capitalized farm in the study was able to engage in 
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this chain, although greater evidence would be needed on the distribution of farm size and 
capitalization to make a firm conclusion. 
The quality benefits for consumers of the captive value chain are clear.  They are able to 
consume a product that is high in key ingredients and low in adulterants.  Tran et al (2013: 
334) have called this a ‘moral beauty contest’, where on the one hand  the rights to consume 
safe and certified products in the industrial North have been expanded, while on the other 
hand the rights of small-scale producers to earn a livelihood in the developing South have 
contracted.  This study complicates Tran et al’s analysis, by suggesting that there may be 
safety hazards for domestic consumers of turmeric, for either food or medicinal use.  These 
hazards are not the result of the development of an organic export value chain, but arise 
because of the competition and volatility of the unregulated domestic market.  This suggests 
that the ‘morality’ of production is quite complex, and that domestic Indian consumers of 
turmeric would benefit from the introduction of health standards. 
 
CONCLUSION 
A growing export market and the activities of international pharmaceutical companies in 
medicinal plant production in India have changed the way that some farmers and processors 
work.  This pattern has to be understood in the light of shifts in standard setting in affluent 
markets.  While some standards are public health regulations, others are privately adopted 
and intended to capture consumer aspirations around product quality.  However, public and 
private standards may have reduced the room for pharmaceutical processors to rely on 
small-scale collectors and farmers.  Indeed, in this case study, international pharmaceutical 
companies are seeking out long-term relationships with primary processors, who themselves 
are entering into long term contracts with larger and more dynamic farmers.  In contrast, 
smaller or non-specialist producers sell onto a volatile ‘free’ domestic market, which 
encourages low quality due to competition and storage.  Thus, this is a complex set of 
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interrelated value chains, where developments in end markets can fundamentally affect the 
structure and benefits of production. 
This particular example suggests that there are a complex set of risks and opportunities for 
different kinds of farmer.  For those dynamic farmers, there is a benefit in terms of relatively 
high price, lack of price volatility, and access to training and inputs.  There are also benefits 
for consumers.  Interestingly, the increased capacity of primary processors to manufacture a 
high quality, organic product has encouraged some to begin to sell to the domestic market, 
and so both affluent Indian and European consumers benefit from a product high in active 
ingredients and free from adulterants.   
It is understandable that researchers are worried about the exclusionary nature of standard 
setting.  This research confirms the results of others studies by suggesting that only certain 
farmers can produce organic medicinal turmeric.  However, the answer is not to simply 
reduce the content of standards, as, in this case, the unregulated market encourages 
production that may be contaminated by mold, heavy metals and pesticides. Indeed, this 
research contradicts other studies that suggest that small farmers are not excluded by public 
health standards in northern countries.  This discussion is also relevant to the debate over 
the development potential of plant-based medicinal, reviewed above, and may support those 
authors, such as Kala et al. (2006) who argue that public intervention is necessary to assist 
small farmers to benefit from the creation of new value chains. 
The strengths of this research are in being able to link a chemical analysis of quality with 
various value chains.  This is the advantage of a multidisciplinary approach that married 
qualitative research with pharmacognosy.  The weaknesses are that it cannot make claims 
to generalizability and further, quantitative investigation may be needed to pin down more 
clearly the pattern of costs and benefits in this value chain.  However, the results are 
certainly challenging and suggest that we should not discount the benefits of either 
integration or standard setting, while recognizing how they are likely to increase farmer 
differentiation.  
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i
 The role of consumer perceptions is also relevant for non-medicinal agricultural trade.  Coslovsky 
(2014:32) notes the impact of both real and imagined health scares, while other agricultural products 
may suddenly move into or out of fashion, such as quinoa or shea butter. 
ii
 Our contrastive case study approach is similar in style to the work of authors, such as DuPuis et al 
(2005), who have investigated alternative food supply systems.  DuPuis et al note how the choice of 
analytical approach can edit out important questions and can direct attention to particular features.  
Thus the discussion of the emergence of new ‘local’ food supply chains has tended to focus attention 
on the internal dynamics of this shift, and neglects the wider questions of the politics and power in the 
supply chain as a whole. 
iii
 Ayurvedic medicine is the most common system of traditional medicine found in India and stems 
from ancient texts of the Hindu religion.   
iv
 The polishing method is used throughout India, either manually or using semi-automated machinery 
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